CXCR4 and neoplasm: In particular, ARI combination determines in both metastatic cells and CSCs strong inhibition of CXCR4, AKT and ERK1/2 pathways, all invasive signals associated with CRC progression, advanced tumor stage, lymphatic recurrence and poor prognosis [54, 55].